Pacific Biosciences of California, Inc. (PACB) vs Sight Sciences, Inc. (SGHT)

Pacific Biosciences of California, Inc. and Sight Sciences, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. and Sight Sciences, Inc. are of similar size ($484.9M and $478.2M). Sight Sciences, Inc. grew revenue faster over the last twelve months: 9.27% against 2.02%. Sight Sciences, Inc. has the higher net margin (−35.7% vs −82.5%) and the lower return on invested capital (−125.2% vs −22.2%). Across the 17 metrics below, Sight Sciences, Inc. leads on 12 and Pacific Biosciences of California, Inc. on 5.

Valuation

Metric PACB SGHT Medical Devices median
P/E n/m n/m 22.18
P/S 3.16 5.84 2.70
P/B n/m 9.20 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 5.72 5.37 2.38
Earnings yield (26.54%) (6.27%) (8.22%)
Free cash flow yield (15.99%) (4.79%) (7.80%)

Profitability

Metric PACB SGHT Medical Devices median
Gross margin 36.38% 87.96% 56.01%
Operating margin (83.53%) (33.43%) (15.03%)
Net margin (82.49%) (35.69%) (20.40%)
Free cash flow margin (50.53%) (27.98%) (7.24%)
Return on equity (929.31%) (48.42%) (15.32%)
Return on assets (16.66%) (26.24%) (19.72%)
Return on invested capital (22.22%) (125.18%) (10.33%)

Growth

Metric PACB SGHT Medical Devices median
Revenue growth (TTM) 2.02% 9.27% 8.80%
EPS growth (last fiscal year) (69.38%) 28.16% —
Revenue growth, 5-year CAGR 15.19% 22.86% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PACB SGHT Medical Devices median
Debt to equity (19.40) 0.77 0.07
Current ratio 4.92 4.95 2.50
Net debt to EBITDA (2.33) 1.45 0.49

Dividend

Metric PACB SGHT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric PACB SGHT Medical Devices median
Market cap 484.89m 478.16m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack